|

Vedolizumab Clinical Trials

4 actively recruiting trials across 3 locations

▲ +2 trials since August 2026

Also known as: Entyvio, Immunoglobulin G1, anti-(human integrin LPAM-1 (lymphocyte Peyer''s patch adhesion molecule 1)) (human-Mus musculus heavy chain), disulfide with human-Mus musculus kappa-chain, dimer, Immunoglobulin G1, anti-(human integrin LPAM-1 (lymphocyte Peyer's patch adhesion molecule 1)) (human-Mus musculus heavy chain), disulfide with human-Mus musculus kappa-chain, dimer, LDP 02, LDP-02 +3 more

Pipeline

Phase 1: 1Phase 2: 2Phase 2/3: 1

Top Sponsors

  • M.D. Anderson Cancer Center1
  • City of Hope Medical Center1
  • Bristol-Myers Squibb1
  • AHS Cancer Control Alberta1

Indications

  • Cancer4
  • Colitis2
  • Lung Cancer2
  • Locally Advanced Non-Small Cell Lung Cancer (NSCLC)1
  • Metastatic Non-small Cell Lung Cancer (NSCLC)1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.